Bristol-Myers Squibb Company (BMY): Price and Financial Metrics
Bristol-Myers Squibb Company (BMY)
Today's Latest Price: $56.48 USD
1.17 (-2.03%)
Updated Nov 19 6:40pm
Add BMY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
BMY Stock Summary
- BMY has a market capitalization of $92,282,690,959 -- more than approximately 97.94% of US stocks.
- BMY's went public 33.9 years ago, making it older than 92.4% of listed US stocks we're tracking.
- With a year-over-year growth in debt of 241.58%, Bristol Myers Squibb Co's debt growth rate surpasses 93.04% of about US stocks.
- If you're looking for stocks that are quantitatively similar to Bristol Myers Squibb Co, a group of peers worth examining would be GILD, QCOM, CELG, TXN, and LLY.
- Visit BMY's SEC page to see the company's official filings. To visit the company's web site, go to www.bms.com.
BMY Daily Price Range
BMY 52-Week Price Range
BMY Stock Price Chart More Charts
BMY Price/Volume Stats
| Current price | $56.48 |
| Prev. close | $57.65 |
| Day low | $56.26 |
| Day high | $57.85 |
| 50-day MA | $53.22 |
| 200-day MA | $48.84 |
| 52-week high | $59.17 |
| 52-week low | $42.48 |
| Volume | 39,249,398 |
| Avg. volume | 15,164,380 |
| Dividend yield | 2.9% |
| Market Cap | 92.02B |
Bristol-Myers Squibb Company (BMY) Company Bio
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular. The company was founded in 1887 and is based in New York, New York.
Top Stories View All
Is Cannabis Stock Aurora Cannabis (ACB) a Buy?
Best & Worst Performing Stock Industries for November 19, 2019
Best & Worst Performing Small Cap Stocks for November 19, 2019
Best & Worst Performing Mid Cap Stocks for November 19, 2019
Best & Worst Performing Large Cap Stocks for November 19, 2019
View All Top Stories
Loading social stream, please wait...